Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Cost of hydromorphone?Nasonex twin pack best price?Does tigecycline's liver enzyme impact efficacy or safety?How do antioxidants affect vascepa's efficacy?Omnaris nasal spray for sinus infection?
See the DrugPatentWatch profile for Sugammadex
Sugammadex (Bridion) received its first European Commission marketing authorization on 20 February 2009.[1]
That date refers to the EC authorization for marketing within the European Union (covering EU-wide availability once the product is launched in individual member states). The approval is distinct from later national launches or label updates.
You can cross-check the date in DrugPatentWatch’s compound/brand coverage for sugammadex (Bridion).[1] Sources: [1] https://drugpatentwatch.com/p/sugammadex
Other Questions About Sugammadex :